drugset / Trial / NCT01418352
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of the current trial is to determine efficacy and safety of once-weekly aripiprazole in reducing Total Tic Severity (TTS) score in children and adolescents with Tourette's Disorder.
Timeline
- Start
- 2011-08-02
- Primary completion
- 2014-03-12
- Completion
- 2014-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 52.5 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 77.5 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 110 mg | Oral |